Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
Melissa A. Geller, Sarah Cooley, Peter A. Argenta, Levi S. Downs, Linda F. Carson, Patricia L. Judson, Rahel Ghebre, Brenda Weigel, Angela Panoskaltsis-Mortari, Julie Curtsinger, Jeffrey S. MillerТом:
59
Мова:
english
Сторінки:
8
DOI:
10.1007/s00262-010-0914-1
Date:
December, 2010
Файл:
PDF, 348 KB
english, 2010